Shanghai Haiyan Pharmaceutical Technology
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 4/1/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (14)
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
Started: 3/25/2025
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
Started: 12/17/2021
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery
Started: 4/1/2025
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery
Started: 4/1/2025
Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
Started: 8/4/2019
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery
Started: 12/26/2023
A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors
Started: 8/11/2023
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
Started: 12/1/2017
A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
Started: 8/31/2024
A Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects
Started: 10/12/2022
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment
Started: 6/3/2024
A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects
Started: 8/22/2024
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
Started: 3/22/2024